Attenuating pregnane X receptor (PXR) activation: A molecular modelling approach

References

• Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Backman M, Ohlsson R, Postlind H, Blomquist P, Berkenstam A. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction, Proceedings of the National Academy of Sciences. USA 1998; 95: 12208–12213
   Google Scholar
• Blumberg B, Sabbagh W, Jr, Juguilon H, Bolado J, Jr, Van Meter CM, Ong ES, Evans RM. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Development 1998; 12: 3195–3205
   PubMed Web of Science ®Google Scholar
• Bolt HM. Rifampicin, a keystone inducer of drug metabolism: From Herbert Remmer's pioneering ideas to modern concepts. Drug Metabolism Review 2004; 36: 497–509
   PubMed Web of Science ®Google Scholar
• Chrencik JE, Orans J, Moore LB, Xue Y, Peng L, Collins JL, Wisely GB, Lambert MH, Kliewer SA, Redinbo MR. Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin. Molecular Endocrinology 2005; 19: 1125–1134
   PubMed Web of Science ®Google Scholar
• Dickins M. Induction of cytochromes P450. Current Topics in Medicine and Chemistry 2004; 4: 1745–1766
   PubMed Web of Science ®Google Scholar
• Durocher Y, Perret S, Thibaudeau E, Gaumond MH, Kamen A, Stocco R, Abramovitz MA. Reporter gene assay for high-throughput screening of G-protein-coupled receptors stably or transiently expressed in HEK293 EBNA cells grown in suspension culture. Annals of Biochemistry 2000; 284: 316–326
   Google Scholar
• Ekins S, Erickson JA. A pharmacophore for human pregnane X receptor ligands. Drug Metabolism and Disposition 2002; 30: 96–99
   PubMed Web of Science ®Google Scholar
• Feuston BP, Miller MD, Culberson JC, Nachbar RB, Kearsley SK. Comparison of knowledge-based and distance geometry approaches for generation of molecular conformations. Journal of Chemistry Information and Computer Science 2001; 41: 754–763
   PubMedGoogle Scholar
• Guengerich FP. Cytochrome P-450 3A4: Regulation and role in drug metabolism. Annual Review in Pharmacology and Toxicology 1999; 39: 1–17
   PubMed Web of Science ®Google Scholar
• Halgren TA. MMFF VI. MMFF94s option for energy minimization studies. Journal of Computational in Chemistry 1999; 20: 720–729
   PubMed Web of Science ®Google Scholar
• Harper S, Avolio S, Pacini B, Di Filippo M, Altamura S, Tomei L, Paonessa G, Di Marco S, Carfi A, Giuliano C, et al. Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase. Journal of Medicine and Chemistry 2005; 48: 4547–4557
   PubMed Web of Science ®Google Scholar
• Jones SA, Moore LB, Shenk JL, Wisley GB, Hamilton GA, McKee DD, Tomkinson NC, Lecluyse EL, Lambert MH, Willson TM, et al. The pregnane X receptor: A promiscuous xenobiotics receptor that has diverged during evolution 2000; 14: 27–39, Molecular Endocrinology
   Google Scholar
• Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterstrom RH, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998; 92: 73–82
   PubMed Web of Science ®Google Scholar
• Kolossvary I, Guida WC. Low mode search. An efficient, automated computational method for conformational analysis: Application to cyclic and acyclic alkanes and cyclic peptides. Journal of American Chemistry and Science 1996; 118: 5011–5019
   Web of Science ®Google Scholar
• Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. Journal of Clinical Investigation 1998; 102: 1016–1023
   PubMed Web of Science ®Google Scholar
• Luo G, Guenthner T, Gan LS, Humphreys WG. CYP3A4 induction by xenobiotics: Biochemistry, experimental methods and impact on drug discovery and development. Current Drug Metabolism 2004; 5: 483–505
   PubMed Web of Science ®Google Scholar
• Maestro GUI. n.d. Version 6.0, Schrodinger L. L. C
   Google Scholar
• Maurel P. Cytochromes P450: Metabolism and toxicological aspects, C Ioannides. CRC Press, Boca Raton, FL 1996; 241–270
   Google Scholar
• Miller MD, Sheridan RP, Kearsley SK. SQ: A program for rapidly producing pharmacophorically relevent molecular superpositions. Journal of Medicine and Chemistry 1999; 42: 1505–1514
   Google Scholar
• Moore JT, Kliewer SA. Use of the nuclear receptor PXR to predict drug interactions. Toxicology 2000; 153: 1–10
   PubMed Web of Science ®Google Scholar
• Moore LB, oodwinB G, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, Kliewer SA. St John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proceedings of the National Academy of Sciences. USA 2000; 97: 7500–7502
   Google Scholar
• Ostberg T, Bertilsson G, Jendeberg L, Berkenstam A, Uppenberg J. Identification of residues in the PXR ligand binding domain critical for species specific and constitutive activation. European Journal of Biochemistry 2002; 269: 4896–4904
   PubMedGoogle Scholar
• Quattrochi LC, Guzelian PS. Cyp3A regulation: From pharmacology to nuclear receptors. Drug Metabolism and Disposition 2001; 29: 615–622
   PubMed Web of Science ®Google Scholar
• Roberts BJ, Song BJ, Soh Y, Park SS, Shoaf SE. Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1. Journal of Biology and Chemistry 1995; 270: 29632–29635
   PubMed Web of Science ®Google Scholar
• Schuster D, Langer T. The identification of ligand features essential for PXR activation by pharmacophore modeling. Journal of Chemistry Information and Modeling 2005; 45: 431–439
   PubMed Web of Science ®Google Scholar
• Shimizu T, Akimoto K, Yoshimura T, Niwa T, Kobayashi K, Tsunoo M, Chiba K. Autoinduction of MKC-963 [R-1-1-cyclohexylethylamino-4-phenylphthalazine] metabolism in healthy volunteers and its retrospective evaluation using primary human hepatocytes and cDNA-expressed enzymes. Drug Metabolism and Disposition 2006; 34: 950–954
   Google Scholar
• Watkins RE, Davis-Searles PR, Lambert MH, Redinbo MR. Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. Journal of Molecular Biology 2003b; 331: 815–828
   PubMed Web of Science ®Google Scholar
• Watkins RE, Maglich JM, Moore LB, Wisely GB, Noble SM Davis-Searles PR, Lambert MH, Kliewer SA, Redinbo MR. 2. 1 A crystal structure of human PXR in complex with the St John's wort compound hyperforin. Biochemistry 2003a; 42: 1430–1438
   PubMed Web of Science ®Google Scholar
• Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA, Redinbo MR. The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity. Science 2001; 292: 2329–2333
   PubMed Web of Science ®Google Scholar
• Xie W, Barwick JL, Downes M, Blumberg B, Simon CM, Nelson MC, Neuschwander-Tetri BA, Brunt EM, Guzelian PS, Evans RM. Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 2000; 406: 435–439
   PubMed Web of Science ®Google Scholar